AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2015
Dec 22, 2015
34129_dirs_2015-12-22_1a42ade1-712a-49eb-a6fe-da0e79da1ec8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2015-12-18
Reporting Person: Koenig Scott (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-18 | Employee Stock Option (right to buy) | $31.43 | A | 150000 | Acquired | 2025-12-18 | Common Stock (150000) | Direct |
Footnotes
F1: 12.5% of the option becomes exercisable on June 18, 2016 and the remaining 87.5% vests in 14 substantially equal quarterly installments thereafter.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18